Micro Emerging Active

ABUS price target reduced on higher appeal probability

New narrative with limited coverage — still forming.

Score
0.5
Velocity
▲ 1.0
Articles
1
Sources
1

Sentiment Timeline

Event Timeline

Apr 18, 2026
Jefferies Sees Reduced Upside for Arbutus Biopharma Corporation (ABUS) on Higher Appeal … Neutral

Related Articles

Jefferies Sees Reduced Upside for Arbutus Biopharma Corporation (ABUS) on Higher Appeal Probability

Yahoo Finance · Apr 18, 2026
Mixed

Timeline

Last UpdatedApr 18, 2026